Advisor Group Holdings, Inc. Taro Pharmaceutical Industries LTD Transaction History

Advisor Group Holdings, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.0 - $42.97 $0 - $8,551	199 New	199 $0
Q4 2023 Feb 12, 2024	BUY	$32.77 - $42.31 $30,148 - $38,925	920 Added 253.44%	1,283 $53,000
Q3 2023 Nov 13, 2023	BUY	$35.46 - $40.13 $9,361 - $10,594	264 Added 266.67%	363 $13,000
Q1 2023 May 12, 2023	BUY	$23.0 - $31.59 $253 - $347	11 Added 12.5%	99 $2,000
Q4 2022 Feb 10, 2023	BUY	$27.6 - $32.99 $441 - $527	16 Added 22.22%	88 $2,000
Q2 2022 Aug 10, 2022	SELL	$35.0 - $43.59 $595 - $741	-17 Reduced 19.1%	72 $3,000
Q1 2022 May 04, 2022	SELL	$43.12 - $50.3 $3,061 - $3,571	-71 Reduced 44.38%	89 $4,000
Q3 2021 Nov 05, 2021	BUY	$62.34 - $73.38 $1,496 - $1,761	24 Added 17.65%	160 $10,000
Q2 2021 Aug 02, 2021	BUY	$70.26 - $76.64 $351 - $383	5 Added 3.82%	136 $10,000
Q1 2021 May 13, 2021	BUY	$70.48 - $79.95 $6,766 - $7,675	96 Added 274.29%	131 $10,000
Q4 2020 Feb 10, 2021	SELL	$54.4 - $73.42 $10,662 - $14,390	-196 Reduced 84.85%	35 $3,000
Q3 2020 Nov 12, 2020	BUY	$54.41 - $68.2 $544 - $682	10 Added 4.52%	231 $13,000
Q1 2020 May 18, 2020	BUY	$59.35 - $88.73 $13,116 - $19,609	221 New	221 $14,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.